Evidence map›Paper›PMID 24604027›Full record

ArticlePLoS pathogens2014

Oncogenic human papillomaviruses activate the tumor-associated lens epithelial-derived growth factor (LEDGF) gene.

Jenny Leitz, Miriam Reuschenbach, Claudia Lohrey, Anja Honegger, Rosita Accardi, Massimo Tommasino, Manuel Llano, Magnus von Knebel Doeberitz, Karin Hoppe-Seyler, Felix Hoppe-Seyler

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. LEDGF/p75 Is Required for an Efficient DNA Damage Response.International journal of molecular sciences · 2021
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. ViralOncotarget · 2017
    Article
  18. Article
  19. The Clinical Relevance of Anti-DFS70 Autoantibodies.Clinical reviews in allergy & immunology · 2017
    Review
  20. Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Jenny LeitzMolecular Therapy of Virus-Associated Cancers (F065), Program Infection and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Miriam ReuschenbachDepartment of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
Claudia LohreyMolecular Therapy of Virus-Associated Cancers (F065), Program Infection and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Anja HoneggerMolecular Therapy of Virus-Associated Cancers (F065), Program Infection and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rosita AccardiInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Massimo TommasinoInternational Agency for Research on Cancer, World Health Organization, Lyon, France.
Manuel LlanoDepartment of Biological Sciences, University of Texas at El Paso, El Paso, Texas, United States of America.
Magnus von Knebel DoeberitzDepartment of Applied Tumor Biology, Institute of Pathology, University of Heidelberg, Heidelberg, Germany.
Karin Hoppe-SeylerMolecular Therapy of Virus-Associated Cancers (F065), Program Infection and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Felix Hoppe-SeylerMolecular Therapy of Virus-Associated Cancers (F065), Program Infection and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Heidelberg University · DECentre International de Recherche sur le Cancer · FRGerman Cancer Research Center · DEThe University of Texas at El Paso · US

Funding

Regulation of the HIV cofactor activity of LEDGF/p75 by interacting proteinsSC1AI098238 · NIAID · UNIVERSITY OF TEXAS EL PASO · PI LLANO, MANUEL · 2011 to 2014
$1.4M
NIAID NIH HHS 5SC1 AI098238-02NIAID NIH HHS SC1 AI098238World Health Organization 001
6 · The paper itself

Abstract

The expression of the human papillomavirus (HPV) E6/E7 oncogenes is crucial for HPV-induced malignant cell transformation. The identification of cellular targets attacked by the HPV oncogenes is critical for our understanding of the molecular mechanisms of HPV-associated carcinogenesis and may open novel therapeutic opportunities. Here, we identify the Lens Epithelial-Derived Growth Factor (LEDGF) gene as a novel cellular target gene for the HPV oncogenes. Elevated LEDGF expression has been recently linked to human carcinogenesis and can protect tumor cells towards different forms of cellular stress. We show that intracellular LEDGF mRNA and protein levels in HPV-positive cancer cells are critically dependent on the maintenance of viral oncogene expression. Ectopic E6/E7 expression stimulates LEDGF transcription in primary keratinocytes, at least in part via activation of the LEDGF promoter. Repression of endogenous LEDGF expression by RNA interference results in an increased sensitivity of HPV-positive cancer cells towards genotoxic agents. Immunohistochemical analyses of cervical tissue specimens reveal a highly significant increase of LEDGF protein levels in HPV-positive lesions compared to histologically normal cervical epithelium. Taken together, these results indicate that the E6/E7-dependent maintenance of intracellular LEDGF expression is critical for protecting HPV-positive cancer cells against various forms of cellular stress, including DNA damage. This could support tumor cell survival and contribute to the therapeutic resistance of cervical cancers towards genotoxic treatment strategies in the clinic.

Indexed as

Cell LineCell Transformation, NeoplasticFemaleGene Expression Regulation, NeoplasticHumansImmunoblottingImmunohistochemistryIntercellular Signaling Peptides and ProteinsOncogene Proteins, ViralPapillomavirus E7 ProteinsPapillomavirus InfectionsRepressor ProteinsReverse Transcriptase Polymerase Chain ReactionRNA, Small InterferingTransfectionUterine Cervical NeoplasmsE6 protein, Human papillomavirus type 16Intercellular Signaling Peptides and Proteinslens epithelium-derived growth factoroncogene protein E7, Human papillomavirus type 16Oncogene Proteins, ViralPapillomavirus E7 ProteinsRepressor ProteinsRNA, Small Interfering

Identifiers

PMID24604027
PMCPMC3946365
OpenAlexW1973000502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.